US equities
|
TSLA
$396.45
▲+6.51%
MU
$903.51
▲+2.96%
SPCX
$149.08
▲+1.08%
NVDA
$217.12
▲+2.92%
META
$643.54
▲+0.14%
SNDK
$1,258.26
▲+1.63%
AAPL
$346.73
▼-0.28%
AMD
$528.14
▲+2.20%
TSLA
$396.45
▲+6.51%
MU
$903.51
▲+2.96%
SPCX
$149.08
▲+1.08%
NVDA
$217.12
▲+2.92%
META
$643.54
▲+0.14%
SNDK
$1,258.26
▲+1.63%
AAPL
$346.73
▼-0.28%
AMD
$528.14
▲+2.20%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about 5/HT1A Receptor agonist
Recent news which mentions 5/HT1A Receptor agonist
Neurolixis expands rare autism disorders research program
June 04, 2024
Tags
Fragile X
Science
Park Ridge
From
PRLog